Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Plaxe

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Gynecologic Oncology|September 1, 1994
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancerS Kirmani, P S Braly, E F McClay, et al.
Investigational New Drugs|December 16, 1998
Phase I and pharmacokinetic study of intraperitoneal topotecanS C Plaxe, R D Christen, J O'Quigley, et al.
American Journal of Clinical Oncology|February 1, 1995
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinomaE F McClay, P D Braly, S Kirmani, et al.
Gynecologic Oncology|October 1, 1993
Phase I and pharmacokinetic study of intraperitoneal ormaplatinS C Plaxe, P S Braly, J L Freddo, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1992
Pharmacokinetic study of intraperitoneal streptozotocinR Goel, E F McClay, S Kirmani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicinR D Christen, E F McClay, S C Plaxe, et al.
Cancer Chemotherapy and Pharmacology|August 24, 1999
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxelS Aebi, T W Schnider, G Los, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxelM M de las Alas, R D Christen, D P Gately, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Gynecologic Oncology|September 1, 1994
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancerS Kirmani, P S Braly, E F McClay, et al.
Investigational New Drugs|December 16, 1998
Phase I and pharmacokinetic study of intraperitoneal topotecanS C Plaxe, R D Christen, J O'Quigley, et al.
American Journal of Clinical Oncology|February 1, 1995
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinomaE F McClay, P D Braly, S Kirmani, et al.
Gynecologic Oncology|October 1, 1993
Phase I and pharmacokinetic study of intraperitoneal ormaplatinS C Plaxe, P S Braly, J L Freddo, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1992
Pharmacokinetic study of intraperitoneal streptozotocinR Goel, E F McClay, S Kirmani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicinR D Christen, E F McClay, S C Plaxe, et al.
Cancer Chemotherapy and Pharmacology|August 24, 1999
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxelS Aebi, T W Schnider, G Los, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxelM M de las Alas, R D Christen, D P Gately, et al.
Pageof 3